Error: Could not add to watchlist. X
+ Watchlist

Shire ViroPharma Inc

VPHM:US
Acquired
VPHM:US was acquired by 0897194D:ID
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.09
Market Cap (USD)
-
Shares Outstanding (m)
65.967
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Shire ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.
Address
730 Stockton Drive
Exton, PA 19341-1171
United States
Phone
1-610-458-7300